Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings

No abstract is available for this paper.

• Publication year

  2010

• Venue

  AIDS (London)

• Publication date

  2010-05-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/QAD.0b013e3283389e26PMID 20299955
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus‐1 mono‐infected patients on antiretroviral therapy

  2009cited by this paper
• Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection.

  2009cited by this paper
• Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study.

  2009cited by this paper
• Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.

  2008cited by this paper
• Noncirrhotic portal hypertension in patients with human immunodeficiency virus-1 infection.

  2008cited by this paper
• Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection

  2008cited by this paper
• Abacavir and increased risk of myocardial infarction.

  2008cited by this paper
• Antiretroviral drugs and liver injury.

  2008cited by this paper
• HCV/ HIV co‐infection: time to re‐evaluate the role of HIV in the liver?

  2008cited by this paper
• Human immunodeficiency virus-related microbial translocation and progression of hepatitis C.

  2008cited by this paper
• Upper Gastrointestinal Bleeding May Unmask Didanosine-Associated Portal Hepatopathy in HIV/HCV Co-infected Patients

  2008cited by this paper
• Antiretroviral-Associated Portal Hypertension: A New Clinical Condition? Prevalence, Predictors and Outcome

  2008cited by this paper
• Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients The SMART/INSIGHT and the D:A:D Study Groups M

  2008cited by this paper
• Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients

  2008cited by this paper
• Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD

  2007cited by this paper
• Thiopurine-Induced Liver Injury in Patients With Inflammatory Bowel Disease: A Systematic Review

  2007cited by this paper
• Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel.

  2007cited by this paper
• Hepatoportal Sclerosis as a Cause of Noncirrhotic Portal Hypertension in Patients With HIV

  2007cited by this paper
• Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients

  2007cited by this paper
• Viral hepatitis in HIV infection.

  2007cited by this paper
• Viral hepatitis in HIV infection.

  2007cited by this paper
• Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine

  2007cited by this paper
• Nodular regenerative hyperplasia: a reversible entity associated with azathioprine therapy.

  2006cited by this paper
• Microbial translocation is a cause of systemic immune activation in chronic HIV infection

  2006cited by this paper
• Microbial translocation is a cause of systemic immune activation in chronic HIV infection

  2006cited by this paper
• Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study.

  2006cited by this paper
• Severe Liver Disease Associated With Prolonged Exposure to Antiretroviral Drugs

  2006cited by this paper
• Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus

  2005cited by this paper
• Early nodular hyperplasia of the liver occurring with inflammatory bowel diseases in association with thioguanine therapy.

  2004cited by this paper
• HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS).

  2002cited by this paper
• COST-EFFECTIVENESS IMPLICATIONS OF THE TIMING OF ANTIRETROVIRAL THERAPY IN HIV-INFECTED ADULTS

  2002cited by this paper
• Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients

  2002cited by this paper
• Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients

  1999cited by this paper
• Histopathology of the liver in non‐cirrhotic portal hypertension of unknown aetiology

  1996cited by this paper

• Drug-induced liver injury. Part II: Late complications and hepatotoxicity monitoring

  2025cites this paper
• Noncirrhotic Portal Hypertension: Current Concepts and Overview of Causes, Pathophysiology, and Imaging Findings.

  2025cites this paper
• Congenital peribronchial myofibroblastic tumors harbor a recurrent EGFR kinase domain duplication.

  2024cites this paper
• Idiopathic non-cirrhotic portal hypertension: A case report

  2024cites this paper
• Porto-sinusoidal Vascular Disease: Classification and Clinical Relevance.

  2024cites this paper
• Nodular regenerative hyperplasia: The role of the CK7 immunohistochemistry pattern of expression in diagnosis.

  2024cites this paper
• Molecular Mechanisms Underlying Vascular Liver Diseases: Focus on Thrombosis

  2023cites this paper
• Porto-sinusoidal vascular disease: a new definition of an old clinical entity

  2023influential citation
• Porto-Sinusoidal Vascular Disorder: A Heretofore Unrecognized Manifestation of Sickle Cell Disease?

  2023cites this paper
• Portal Hypertension Due to Hepatoportal Sclerosis in an HIV-Positive Patient Secondary to Didanosine Use

  2023cites this paper
• Portal vein thrombosis, hepatic decompensation, and survival in patients with porto-sinusoidal vascular disease and portal hypertension

  2023cites this paper
• Splenomegaly is a marker of advanced chronic liver disease and portal hypertension in HIV infection

  2022cites this paper
• Pediatric non-cirrhotic portal hypertension: Endoscopic outcome and perspectives from developing nations

  2021cites this paper
• Drug induced liver injury and vascular liver disease.

  2020cites this paper
• Non-cirrhotic portal hypertension in inflammatory bowel disease.

  2020cites this paper
• EASL Clinical Practice Guidelines: Drug-induced liver injury.

  2019cites this paper
• EASL Clinical Practice Guidelines: Drug-induced liver injury

  2019cites this paper
• Successful treatment of noncirrhotic portal hypertension with eculizumab in paroxysmal nocturnal hemoglobinuria: A case report

  2019cites this paper
• Clinical significance of elevated liver transaminases in HIV-infected patients.

  2019cites this paper
• Noncirrhotic Portal Hypertension: Current and Emerging Perspectives.

  2019cites this paper
• Porto-sinusoidal vascular disease: proposal and description of a novel entity.

  2019cites this paper
• Histopathological challenges in suspected drug‐induced liver injury

  2018cites this paper
• AIDS Clinical Research in Spain—Large HIV Population, Geniality of Doctors, and Missing Opportunities

  2018cites this paper
• Obliterative portal venopathy: A histopathologic finding associated with chronic antibody‐mediated rejection in pediatric liver allografts

  2018cites this paper
• Idiopathic portal hypertension and extrahepatic portal venous obstruction

  2018cites this paper
• Portal Vein Thrombosis: Imaging the Spectrum of Disease With an Emphasis on MRI Features.

  2018cites this paper
• Nodular Regenerative Hyperplasia

  2017cites this paper
• Changing clinical profile and factors associated with liver enzyme abnormalities among HIV-infected persons

  2017cites this paper
• Human Immunodeficiency Virus Infection, Antiretroviral Therapy, and Liver Pathology.

  2017cites this paper
• The Impact of New Technologic and Molecular Advances in the Daily Practice of Gastrointestinal and Hepatobiliary Pathology.

  2017cites this paper
• Noncirrhotic Portal Hypertension in Perinatally HIV-infected Adolescents Treated With Didanosine-containing Antiretroviral Regimens in Childhood

  2016cites this paper
• Progression of Hepatic Adenoma to Carcinoma in the Setting of Hepatoportal Sclerosis in HIV Patient: Case Report and Review of the Literature

  2016cites this paper
• Idiopathic noncirrhotic portal hypertension: current perspectives

  2016cites this paper
• Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons

  2016cites this paper
• Histological Spectrum of Idiopathic Noncirrhotic Portal Hypertension in Liver Biopsies From Dialysis Patients

  2015cites this paper
• Baseline prevalence and predictors of liver fibrosis among HIV‐positive individuals: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

  2015cites this paper
• Chronic liver disease in the human immunodeficiency virus patient.

  2015cites this paper
• [Idiopathic non-cirrhotic portal hypertension: An update].

  2015cites this paper
• Idiopathic non-cirrhotic portal hypertension: a review

  2015cites this paper
• Hepatoportal Sclerosis as a Cause of Portal Hypertension in a Colombian HIV patient without Cirrhosis

  2015cites this paper
• Esclerosis hepatoportal como causa de hipertensión portal no cirrótica en un paciente colombiano infectado con VIH

  2015cites this paper
• Non-cirrhotic portal hypertension--concept, diagnosis and clinical management.

  2014cites this paper
• Human immunodeficiency virus and liver disease forum 2012

  2014cites this paper
• Clinical factors that predict noncirrhotic portal hypertension in HIV-infected patients: a proposed diagnostic algorithm.

  2014cites this paper
• Human immunodeficiency virus and nodular regenerative hyperplasia of liver: A systematic review.

  2014cites this paper
• Idiopathic Non-Cirrhotic Intrahepatic Portal Hypertension (NCIPH)-Newer Insights into Pathogenesis and Emerging Newer Treatment Options.

  2014cites this paper
• Analysis of the hepatic functional reserve, portal hypertension, and prognosis of patients with human immunodeficiency virus/hepatitis C virus coinfection through contaminated blood products in Japan.

  2014cites this paper
• Non-cirrhotic portal hypertension.

  2014influential citation
• Liver transplantation for patients with human immunodeficiency virus and hepatitis C virus co‐infection: update in 2013

  2014cites this paper
• Liver transplantation for HIV/hepatitis C virus co‐infected patients

  2014cites this paper
• Non-cirrhotic portal hypertension - diagnosis and management.

  2014cites this paper
• HIV/HCV重複感染患者の肝障害病期診断におけるacoustic radiation force impulse（ARFI）elastographyの有用性

  2014cites this paper
• The efficacy of the ImmuKnow assay for evaluating the immune status in human immunodeficiency virus and hepatitis C virus-coinfected patients.

  2014cites this paper
• Metabolomics Discloses Potential Biomarkers for the Noninvasive Diagnosis of Idiopathic Portal Hypertension

  2013cites this paper
• Histopathologic manifestations of drug-induced hepatotoxicity.

  2013cites this paper
• LIVER FUNCTION MARKERS AND ASSOCIATED SERUM ELECTROLYTES CHANGES IN HIV PATIENTS ATTENDING PATIENT SUPPORT CENTRE OF JARAMOGI OGINGA ODINGA TEACHING AND REFERRAL HOSPITAL, KISUMU COUNTY, KENYA.

  2013cites this paper
• Lengthy Follow-up After Liver Transplantation for Nodular Regenerative Hyperplasia in Human Immunodeficiency Virus–Infected Patients: Does the Disease Recur?

  2013cites this paper
• Etiology and Clinical Outcomes of Idiopathic Nondrrhotic Portal Hypertension

  2013cites this paper
• Obliterative Portal Venopathy: A Clinical and Histopathological Review

  2013cites this paper
• Avances en el diagnóstico, etiopatogenia y pronóstico de la hipertensión portal no cirrótica

  2013cites this paper
• Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study.

  2013cites this paper
• Hepatoportal Sclerosis in Childhood: Descriptive Analysis of

  2013cites this paper
• Hepatotoxicity of Antiviral Agents

  2013cites this paper
• Genetic determinants of idiopathic noncirrhotic portal hypertension in HIV-infected patients.

  2013cites this paper
• Hepatoportal Sclerosis in Childhood: Descriptive Analysis of 12 Patients

  2013cites this paper
• An unusual cause of oesophageal variceal bleeding in a Chinese human immunodeficiency virus-infected patient.

  2013cites this paper
• Non‐cirrhotic portal hypertension in HIV mono‐infected patients

  2012cites this paper
• Splenomegaly and variceal bleeding in a ten-year-old HIV-infected girl with noncirrhotic portal hypertension.

  2012cites this paper
• Case 183: Obliterative portal venopathy.

  2012cites this paper
• Minimizing the risk of non-vertical, non-sexual HIV infection in children – beyond mother to child transmission

  2012cites this paper
• Human immunodeficiency virus infection and the liver.

  2012cites this paper
• Management of hepatic vascular diseases.

  2012cites this paper
• Noncirrhotic portal hypertension associated with didanosine: a case report and literature review.

  2012cites this paper
• Severe transaminitis after interferon–ribavirin therapy in HIV/HCV‐coinfected patients: influence of a sustained HCV response

  2012cites this paper
• Liver Toxicity of Antiretroviral Drugs

  2012cites this paper
• Management and Treatment of Chronic Hepatitis C in HIV Patients

  2012cites this paper
• Venous and Arterial Thromboembolic Complications Associated with HIV Infection and Highly Active Antiretroviral Therapy

  2012cites this paper
• Central role of mitochondria in drug-induced liver injury

  2012cites this paper
• Risk factors and outcome of HIV‐associated idiopathic noncirrhotic portal hypertension

  2012cites this paper
• 8 – Other viral and infectious diseases and HIV-related liver disease

  2012cites this paper
• Clinical implications of immune recovery during antiretroviral treatment for HIV infection

  2012cites this paper
• Pathology of HIV-Associated Liver Disease

  2012cites this paper
• Short Communication Noncirrhotic Portal Hypertension Associated with Didanosine: a Case Report and Literature Review

  2012cites this paper
• Cryptogenic liver diseases: sailing by sight from HIV co-infection with hepatitis viruses to HIV mono-infection through the Pillars of Hercules.

  2011cites this paper
• Immunopathogenesis of HIV/hepatitis C virus coinfection

  2011cites this paper
• Hepatobiliary Manifestations of Human Immunodeficiency Virus

  2011cites this paper
• Anaesthesia and intensive care in patients with HIV

  2011cites this paper
• Increasing burden of liver disease in patients with HIV infection.

  2011cites this paper
• Noncirrhotic portal hypertension in HIV infection

  2011cites this paper
• Didanosine Exposure and Noncirrhotic Portal Hypertension in a HIV Clinic in North America: a Follow-up Study.

  2011cites this paper
• Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertension.

  2011cites this paper
• Human immunodeficiency virus and liver disease forum 2010: Conference proceedings

  2011cites this paper
• The role of nucleoside and nucleotide analogues in nodular regenerative hyperplasia in HIV-infected patients: a case control study.

  2011cites this paper
• Influence of antiretroviral therapy on liver disease

  2011cites this paper
• Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection.

  2011cites this paper
• Idiopathic noncirrhotic portal hypertension

  2011cites this paper
• Noncirrhotic Portal Hypertension in HIV-Infected Patients: A Case Control Evaluation and Review of the Literature

  2010cites this paper
• Clinical syndromes and consequences of antiretroviral‐related hepatotoxicity

  2010cites this paper